Find latest Non-Small Cell Lung Cancer videos · 500+ videos

ESMO Asia 2023 Insights: "Efficacy & Safety of MCLA-129, an Anti-EGFR/c-MET Bispecific Antibody, Combined With Osimertinib, as 1L Therapy or After Progression on Osimertinib in NSCLC"

82 views
January 17, 2024
Comments 0
Login to view comments. Click here to Login